Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPOWER: Restasis in dry eye with electronic visual tasking
NCT02554981Phase 4Completed
- Sponsor
- Allergan
- Start
- Jul 2015
- Primary completion
- Mar 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cyclosporine ophthalmic solution in dry eye syndrome (DED), sponsored by Allergan. Primary endpoints: Total Corneal Staining Score With Fluorescein in the Worse Eye at Month 6, Total Conjunctival Staining Score With Fluorescein in the Worse Eye at Month 6 and 8 more. Started Jul 2015; status: completed.
02
Drugs
cyclosporine ophthalmic solution
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT02554981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02554981.